Inhibition of notch signaling in combination with Paclitaxel reduces platinum-resistant ovarian tumor growth. - sprookjes - yvandenbroek - TriplyDB

Inhibition of notch signaling in combination with Paclitaxel reduces platinum-resistant ovarian tumor growth.

Inhibition of notch signaling in combination with Paclitaxel reduces platinum-resistant ovarian tumor growth.

http://www.wikidata.org/entity/Q33851035

about

Protein Kinase Cι Drives a NOTCH3-dependent Stem-like Phenotype in Mutant KRAS Lung Adenocarcinoma Notch signaling in serous ovarian cancer.The promise and challenge of ovarian cancer models.Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study.Histologic and molecular analysis of patient derived xenografts of high-grade serous ovarian carcinoma.Oral cancer cells sustainedly infected with Porphyromonas gingivalis exhibit resistance to Taxol and have higher metastatic potential.Synergistic Effect of Notch-3-Specific Inhibition and Paclitaxel in Non-Small Cell Lung Cancer (NSCLC) Cells Via Activation of The Intrinsic Apoptosis Pathway.HES1 Promotes Colorectal Cancer Cell Resistance To 5-Fu by Inducing Of EMT and ABC Transporter Proteins.

P2860

Q28115044-6146B3FB-F973-4A62-83CD-E58BFFE5867B Q34491211-652BF52E-8BED-4F43-802C-7A58F7EAED75 Q35771750-9A8EC661-2204-4C5C-A26E-63691BFEDFCA Q36378403-5E4465C6-61CD-4E34-97F6-987B4D63D2C4 Q37272622-234742BD-3D59-48EB-AE29-BB478ADD0019 Q40260364-9B8C1BB6-EF2B-493E-8E5E-70E1D864406B Q41360028-7165C046-469F-4F0F-B02D-EF63A76CC179 Q41721768-3EA103BE-C569-48F0-940A-C0C14B33077F

P2860

Inhibition of notch signaling in combination with Paclitaxel reduces platinum-resistant ovarian tumor growth.

http://www.wikidata.org/entity/Q33851035

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Inhibition of notch signaling ...... esistant ovarian tumor growth.

@ast

Inhibition of notch signaling ...... esistant ovarian tumor growth.

@en

type

label

Inhibition of notch signaling ...... esistant ovarian tumor growth.

@ast

Inhibition of notch signaling ...... esistant ovarian tumor growth.

@en

prefLabel

Inhibition of notch signaling ...... esistant ovarian tumor growth.

@ast

Inhibition of notch signaling ...... esistant ovarian tumor growth.

@en

P1433

Q33851035-8D670B05-C291-48E3-A231-01B0EE780E8C

P1476

Q33851035-AAA5B9F2-685C-4C2A-9369-9784153B3BF6

P2093

Q33851035-4ECA97E0-714D-4426-8D7C-3D3E40F98B43

Q33851035-51AA1C97-BF22-4510-B22D-F4EDAFAEBADC

Q33851035-520DC67F-A26D-49CA-A125-3657C2946714

Q33851035-582DB814-95D9-4B68-8241-E91CF01F3AC1

Q33851035-5E5F4059-2A4B-4443-B342-BB037A1E530C

Q33851035-E29CF9CD-10D4-4D4E-8DCC-43C63C341DF2

Q33851035-E625F7C7-CB7A-41B8-8DBE-7E7C6B5E70B1

Q33851035-F2688381-146C-4F62-A9DF-2C67E4A5666B

P2860

Q33851035-08C81F10-FF3F-49DB-BC66-1F70921897C4

Q33851035-1074FF5B-B140-40EB-9ECA-5F18EF628338

Q33851035-1306F13F-F200-49D9-B511-DA874955375E

Q33851035-15D849D0-B106-4752-B803-388C4A91D129

Q33851035-19B46CBA-8749-41DF-8353-B415EC1A89CE

Q33851035-1BB9B39E-F3D5-4843-B817-1DD293FC5BD0

Q33851035-1D80D1CE-C025-46DA-A101-48146ADE5C61

Q33851035-1D90D1BC-C43B-48A5-9C1D-282A773E0BEF

Q33851035-1E185296-FE06-4570-BB20-9EBDEC735866

Q33851035-20D0BBDF-52AF-4DE0-9DDC-56A6467B1A7D

P304

Q33851035-5DA4CCAD-6B3E-4F3E-BE2F-212CAF8F4C3F

P31

Q33851035-7361EFE5-8D0E-41EB-9D44-737A6EAA85AA

P356

Q33851035-7785E2A0-BE07-4C89-9811-37FB2E1F27D2

P478

Q33851035-F4F418F0-D570-49AC-AA33-A1BD696D8864

P577

Q33851035-91A1C133-BD57-49D2-A3CE-A6B48BF82320

P5875

Q33851035-F1DE41C3-367B-4B23-997A-358BFD09D56E

P698

Q33851035-82C171BE-2CB1-4452-B2A1-3A136586DD8D

P932

Q33851035-86C26812-061C-4041-874B-5C9C0FC51018

P356

FONC.2014.00171

P1433

Frontiers in Oncology

P1476

Inhibition of notch signaling ...... esistant ovarian tumor growth.

@en

P2093

Bo R Rueda

http://www.w3.org/2001/XMLSchema#string

Celeste M DiGloria

http://www.w3.org/2001/XMLSchema#string

Jing Yuan

http://www.w3.org/2001/XMLSchema#string

Jolijn W Groeneweg

http://www.w3.org/2001/XMLSchema#string

Rosemary Foster

http://www.w3.org/2001/XMLSchema#string

Sriram Sathyanarayanan

http://www.w3.org/2001/XMLSchema#string

Whitfield B Growdon

http://www.w3.org/2001/XMLSchema#string

William S Richardson

http://www.w3.org/2001/XMLSchema#string

P2860

Identification and characterization of ovarian cancer-initiating cells from primary human tumors

Stem cells living with a Notch

Cancer treatment and survivorship statistics, 2012

Inhibition of Hedgehog signaling antagonizes serous ovarian cancer growth in a primary xenograft model

Integrated genomic analyses of ovarian carcinoma

Cancer statistics, 2012

A new mathematical model for relative quantification in real-time RT-PCR

The canonical Notch signaling pathway: unfolding the activation mechanism.

Notch signaling in cancer.

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study.

P304

171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FONC.2014.00171

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264393304

http://www.w3.org/2001/XMLSchema#string

P698

25072022

http://www.w3.org/2001/XMLSchema#string

P932

4083224

http://www.w3.org/2001/XMLSchema#string